NCT05485064

Brief Summary

The purpose of this study is mainly about the feasibility and rationality of moderate sedation combined with acupuncture anesthesia in the application of gastroscopy and colonoscopy ,Then we evaluate the effectiveness and advantages of the combination of acupuncture anesthesia and drug anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 3, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2022

Completed
Last Updated

November 4, 2022

Status Verified

November 1, 2022

Enrollment Period

3 months

First QC Date

July 29, 2022

Last Update Submit

November 2, 2022

Conditions

Keywords

eletroacupuncturemoderate sedationremimazolamtranscutaneous electrical acupuncture point stimulation

Outcome Measures

Primary Outcomes (3)

  • patient satisfaction with sedation instrument,PSSI

    The investigator 2 needs to use VAS scores to evaluate satisfaction about sedation feeling when they accepted gastroscopy and colonoscopy .The score ranges from 0 to10 and need patients evaluate it by themself when the gastroscopy or colonoscopy were finished.The score from 0 (extremely dissatisfied)to 10(extremely satisfied).

    During gastroscopy and colonoscopy

  • clinical satisfaction with sedation instrument,CSSI

    The investigator 2 needs to use VAS scores to evaluate satisfaction about doctors when they carry out the operation.The score from 0 (extremely dissatisfied)to 10(extremely satisfied).

    During gastroscopy and colonoscopy

  • patient's pain score

    The investigator 2 needs to use VAS scores to evaluate patients' pain score .The score from 0 (extremely dissatisfied)to 10(extremely satisfied).

    During gastroscopy and colonoscopy

Secondary Outcomes (10)

  • the extent of cardia exposure

    During gastroscopy and colonoscopy

  • adverse reactions

    During gastroscopy and colonoscopy

  • patient's recovery time

    The end of gastroscopy and colonoscopy

  • patient's departure time

    The end of gastroscopy and colonoscopy

  • time to resume normal operation

    The end of gastroscopy and colonoscopy

  • +5 more secondary outcomes

Study Arms (3)

electroacupuncture(transcutaneous electrical acupuncture point stimulation )and remimazolam

EXPERIMENTAL

The investigator 1 combine electroacupuncture(transcutaneous acupoint electrical stimulation ) with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy.

Procedure: eletroacupuncture(transcutaneous electrical acupuncture point stimulation )Drug: remimazolam

placebo needle and remimazolam

EXPERIMENTAL

The investigator 1 combine placebo needle with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy.

Drug: placebo needleDrug: remimazolam

fentanyl and remimazolam

EXPERIMENTAL

The investigator 1 combine fentanyl with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy.

Drug: fentanylDrug: remimazolam

Interventions

The investigator 1 use fentanyl to sedate patients coordinate with remimazolam

fentanyl and remimazolam

The investigator 1 use electroacupunture(transcutaneous electrical acupuncture point stimulation )to coordinate with remimazolam

electroacupuncture(transcutaneous electrical acupuncture point stimulation )and remimazolam

The investigator 1 use placebo needle to sedate patients coordinate with remimazolam

placebo needle and remimazolam

The investigator 1 use remimazolam to sedate patients coordinate with eletroacupuncture(transcutaneous electrical acupuncture point stimulation )or placebo needle

electroacupuncture(transcutaneous electrical acupuncture point stimulation )and remimazolamfentanyl and remimazolamplacebo needle and remimazolam

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Outpatients
  • Patients with ASA grade I-III
  • A sufficient level of education to understand study procedures and can communicate with investigators.

You may not qualify if:

  • Patients with serious systemic diseases such as severe cardiopulmonary disease or hepatic diseases or renal diseases.
  • Patients under the age of 18.
  • Patients who did not sign the informed consent form.
  • Patients who have a history of alcohol abuse or drug abuse.
  • People who are allergic to anesthetic related ingredients, such as soybeans, eggs and so on.
  • Patients with extreme fear or anxiety about acupuncture.
  • Patients with relative contraindications of gastrointestinal endoscopy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jixiangyu

Qingdao, Shandong, 266000, China

Location

Related Publications (6)

  • Eberl S, Monteiro de Olivera N, Bourne D, Streitberger K, Fockens P, Hollmann MW, Preckel B. Effect of electroacupuncture on sedation requirements during colonoscopy: a prospective placebo-controlled randomised trial. Acupunct Med. 2020 Jun;38(3):131-139. doi: 10.1136/acupmed-2017-011459. Epub 2020 Jan 22.

    PMID: 31968988BACKGROUND
  • Yu B, Hazlewood PJ, Yin X, Li S, Yue H, Xu K, Xu S, Mi Y. Effect of electroacupuncture on discomfort during gastroscopy: a study protocol for a randomized controlled trial. Trials. 2022 Apr 27;23(1):364. doi: 10.1186/s13063-022-06165-4.

    PMID: 35477483BACKGROUND
  • Cohen LB, Hightower CD, Wood DA, Miller KM, Aisenberg J. Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest Endosc. 2004 Jun;59(7):795-803. doi: 10.1016/s0016-5107(04)00349-9.

    PMID: 15173791BACKGROUND
  • Qin Z, Ding Y, Xu C, Kwong JSW, Ji Y, Wu A, Wu J, Liu Z. Acupuncture vs Noninsertive Sham Acupuncture in Aging Patients with Degenerative Lumbar Spinal Stenosis: A Randomized Controlled Trial. Am J Med. 2020 Apr;133(4):500-507.e20. doi: 10.1016/j.amjmed.2019.08.038. Epub 2019 Sep 13.

    PMID: 31525334BACKGROUND
  • Chen JM, Li DD, Chen YS, Lian B, Wang XP, Guo YH, Xu XL, Huang P, Chen TF, Liu Y, Liu QQ. The effectiveness of electro-acupuncture combined with dyclonine hydrochloride in relieving the side effects of gastroscopy: a controlled trial. Ann Palliat Med. 2021 Mar;10(3):2958-2970. doi: 10.21037/apm-20-831. Epub 2021 Mar 1.

  • Xu JH, Tan HL, Zhang LN, Zhou ZG, Yuan L, Kong LX, Song MQ, Qi LJ, Ji XY. Transcutaneous Electrical Acupoint Stimulation Combined with Moderate Sedation of Remimazolam Tosilate in Gastrointestinal Endoscopy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Pain Ther. 2024 Aug;13(4):919-936. doi: 10.1007/s40122-024-00618-1. Epub 2024 Jun 18.

MeSH Terms

Interventions

Fentanylremimazolam

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
During the examination, the acupuncture position was blocked to ensure that the acupuncture position was not visible; except for researcher 1, the only researcher who knew about the grouping of patients,All trial-related data were recorded by researcher 2 , and researcher 1 was responsible for patients'sedation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate chief physician

Study Record Dates

First Submitted

July 29, 2022

First Posted

August 3, 2022

Study Start

August 1, 2022

Primary Completion

November 3, 2022

Study Completion

November 3, 2022

Last Updated

November 4, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will share
Shared Documents
ICF

Locations